Acquired torticollis

Stacy M. Epidemiology, clinical presentation, and diagnosis of cervical dystonia. Neurol Clin. 2008 May;26(suppl 1):23-42. Resumen

Singer C, Velickovic M. Cervical dystonia: etiology and pathophysiology. Neurol Clin. 2008 May;26(suppl 1):9-22. Resumen

Colosimo C, Suppa A, Fabbrini G, et al. Craniocervical dystonia: clinical and pathophysiological features. Eur J Neurol. 2010 Jul;17(suppl 1):15-21. Resumen

Rodrigues FB, Duarte GS, Marques RE, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633.Texto completo  Resumen

Dashtipour K, Lew M. Cervical dystonia. In: Stacy MA, ed. Handbook of dystonia. New York, NY: Informa Healthcare; 2007:137-53.

Jankovic J, Leder S, Warner D, et al. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul;41(7):1088-91. Resumen

1. Stacy M. Epidemiology, clinical presentation, and diagnosis of cervical dystonia. Neurol Clin. 2008 May;26(suppl 1):23-42. Resumen

2. Marras C, Van den Eeden SK, Fross RD, et al. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology. 2007 Aug 14;69(7):676-80. Resumen

3. LaHue SC, Albers K, Goldman S, et al. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020 Mar;35(3):450-6.Texto completo  Resumen

4. Papantonio AM, Beghi E, Fogli D, et al. Prevalence of primary focal or segmental dystonia in adults in the district of foggia, southern Italy: a service-based study. Neuroepidemiology. 2009;33(2):117-23. Resumen

5. Martino D, Aniello MS, Masi G, et al. Validity of family history data on primary adult-onset dystonia. Arch Neurol. 2004 Oct;61(10):1569-73.Texto completo  Resumen

6. Defazio G, Aniello MS, Masi G, et al. Frequency of familial aggregation in primary adult-onset cranial cervical dystonia. Neurol Sci. 2003 Oct;24(3):168-9. Resumen

7. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6(2):119-26. Resumen

8. Singer C, Velickovic M. Cervical dystonia: etiology and pathophysiology. Neurol Clin. 2008 May;26(suppl 1):9-22. Resumen

9. Sun YV, Li C, Hui Q, et al. A multi-center genome-wide association study of cervical dystonia. Mov Disord. 2021 Dec;36(12):2795-801.Texto completo  Resumen

10. Samii A, Pal PK, Schulzer M, et al. Post-traumatic cervical dystonia: a distinct entity? Can J Neurol Sci. 2000 Feb;27(1):55-9. Resumen

11. van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull. 1999;25(4):741-8.Texto completo  Resumen

12. Delnooz CC, Pasman JW, Beckmann CF, et al. Altered striatal and pallidal connectivity in cervical dystonia. Brain Struct Funct. 2015 Jan;220(1):513-23. Resumen

13. Colosimo C, Suppa A, Fabbrini G, et al. Craniocervical dystonia: clinical and pathophysiological features. Eur J Neurol. 2010 Jul;17(suppl 1):15-21. Resumen

14. Pantano P, Totaro P, Fabbrini G, et al. A transverse and longitudinal MR imaging voxel-based morphometry study in patients with primary cervical dystonia. AJNR Am J Neuroradiol. 2011 Jan;32(1):81-4. Resumen

15. Werle RW, Takeda SY, Zonta MB, et al. The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia. Arq Neuropsiquiatr. 2014 Jun;72(6):405-10. Resumen

16. Muller J, Wissel J, Masuhr F, et al. Clinical characteristics of the geste antagoniste in cervical dystonia. J Neurol. 2001 Jun;248(6):478-82. Resumen

17. Jahanshahi M. Factors that ameliorate or aggravate spasmodic torticollis. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):227-9.Texto completo  Resumen

18. Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011 Jan;18(1):5-18.Texto completo  Resumen

19. Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol. 2006 May;13(5):433-44.Texto completo  Resumen

20. De Pauw J, Van der Velden K, Meirte J, et al. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol. 2014 Oct;261(10):1857-65.Texto completo  Resumen

21. Delnooz CC, Horstink MW, Tijssen MA, van de Warrenburg BP. Paramedical treatment in primary dystonia: a systematic review. Mov Disord. 2009 Nov 15;24(15):2187-98. Resumen

22. Hu W, Rundle-Gonzalez V, Kulkarni SJ, et al. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia. Parkinsonism Relat Disord. 2019 Jun;63:195-8.Texto completo  Resumen

23. Duarte GS, Castelão M, Rodrigues FB, et al. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev. 2016 Oct 26;(10):CD004314.Texto completo  Resumen

24. Comella CL, Jankovic J, Shannon KM, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology. 2005 Nov 8;65(9):1423-9. Resumen

25. Camargo CH, Teive HA, Becker N, et al. Botulinum toxin type A and cervical dystonia: a seven-year follow-up. Arq Neuropsiquiatr. 2011 Oct;69(5):745-50.Texto completo  Resumen

26. Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache - report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2016 May 10;86(19):1818-26.Texto completo  Resumen

27. Brans JW, Lindeboom R, Snoek JW, et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology. 1996 Apr;46(4):1066-72. Resumen

28. Brashear A. Botulinum toxin type A in the treatment of patients with cervical dystonia. Biologics. 2009;3:1-7.Texto completo  Resumen

29. Truong D, Duane DD, Jankovic J, et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005 Jul;20(7):783-91. Resumen

30. Comella CL, Jankovic J, Truong DD, et al. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(®), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011 Sep 15;308(1-2):103-9. Resumen

31. Marques RE, Duarte GS, Rodrigues FB, et al. Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev. 2016 May 13;(5):CD004315.Texto completo  Resumen

32. Pappert EJ, Germanson T; Myobloc/Neurobloc European Cervical Dystonia Study Group. Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord. 2008 Mar 15;23(4):510-7. Resumen

33. Rodrigues FB, Duarte GS, Marques RE, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633.Texto completo  Resumen

34. Yi YG, Kim K, Yi Y, et al. Botulinum toxin type A injection for cervical dystonia in adults with dyskinetic cerebral palsy. Toxins (Basel). 2018 May 16;10(5):E203.Texto completo  Resumen

35. Marsh WA, Monroe DM, Brin MF, et al. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurol. 2014 Apr 27;14:91.Texto completo  Resumen

36. Nijmeijer SW, Koelman JH, Kamphuis DJ, et al. Muscle selection for treatment of cervical dystonia with botulinum toxin-a systematic review. Parkinsonism Relat Disord. 2012 Jul;18(6):731-6. Resumen

37. Castagna A, Albanese A. Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance. Neurol Clin Pract. 2019 Feb;9(1):64-73.Texto completo  Resumen

38. Hong JS, Sathe GG, Niyonkuru C, et al. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve. 2012 Oct;46(4):535-9. Resumen

39. Swope D, Barbano R. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin. 2008 May;26(suppl 1):54-65. Resumen

40. Coleman C, Hubble J, Schwab J, et al. Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA. Int J Neurosci. 2012 Jul;122(7):358-62. Resumen

41. Tassorelli C, Mancini F, Balloni L, et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord. 2006 Dec;21(12):2240-3. Resumen

42. Apkon SD, Cassidy D. Safety considerations in the use of botulinum toxins in children with cerebral palsy. PM R. 2010 Apr;2(4):282-4. Resumen

43. Kiss ZH, Doig-Beyaert K, Eliasziw M, et al. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain. 2007 Nov;130(Pt 11):2879-86.Texto completo  Resumen

44. Rodrigues FB, Duarte GS, Prescott D, et al. Deep brain stimulation for dystonia. Cochrane Database of Systematic Rev. 2019 Jan 10;(1):CD012405.Texto completo

45. Volkmann J, Mueller J, Deuschl G, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014 Sep;13(9):875-84. Resumen

46. Cacciola F, Farah JO, Eldridge PR, et al. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery. 2010 Oct;67(4):957-63. Resumen

47. Skogseid IM, Ramm-Pettersen J, Volkmann J, et al. Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study. Eur J Neurol. 2012 Apr;19(4):610-5. Resumen

48. Ostrem JL, Racine CA, Glass GA, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology. 2011 Mar 8;76(10):870-8. Resumen

49. Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, et al. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg. 2003 Jun;98(6):1247-54. Resumen

50. Wang J, Li J, Han L, et al. Selective peripheral denervation for the treatment of spasmodic torticollis: long-term follow-up results from 648 patients. Acta Neurochir (Wien). 2015 Mar;157(3):427-33; discussion 433. Resumen

51. Huh R, Han IB, Chung M, et al. Comparison of treatment results between selective peripheral denervation and deep brain stimulation in patients with cervical dystonia. Stereotact Funct Neurosurg. 2010;88(4):234-8. Resumen

52. Chung M, Han I, Chung SS, et al. Effectiveness of selective peripheral denervation in combination with pallidal deep brain stimulation for the treatment of cervical dystonia. Acta Neurochir (Wien). 2015 Mar;157(3):435-42. Resumen

53. Takeuchi N, Chuma T, Mano Y. Phenol block for cervical dystonia: effects and side effects. Arch Phys Med Rehabil. 2004 Jul;85(7):1117-20. Resumen

54. Lew MF, Brashear A, Factor S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology. 2000;55(12 suppl 5):S29-35. Resumen

55. Dashtipour K, Lew M. Cervical dystonia. In: Stacy MA, ed. Handbook of dystonia. New York, NY: Informa Healthcare; 2007:137-53.

56. Jahanshahi M, Marion MH, Marsden CD. Natural history of adult-onset idiopathic torticollis. Arch Neurol. 1990 May;47(5):548-52. Resumen

57. Camfield L, Ben-Shlomo Y, Warner TT. Impact of cervical dystonia on quality of life. Mov Disord. 2002 Jul;17(4):838-41. Resumen

58. Slawek J, Friedman A, Potulska A, et al. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol. 2007 Apr-Jun;22(2):95-100. Resumen

59. Rinnerthaler M, Mueller J, Weichbold V, et al. Social stigmatization in patients with cranial and cervical dystonia. Mov Disord. 2006 Oct;21(10):1636-40. Resumen

60. Rondot P, Marchand MP, Dellatolas G. Spasmodic torticollis--review of 220 patients. Can J Neurol Sci. 1991 May;18(2):143-51. Resumen

61. Jankovic J, Leder S, Warner D, et al. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul;41(7):1088-91. Resumen

62. Molho ES, Agarwal N, Regan K, et al. Effect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment status. Mov Disord. 2009 Jul 15;24(9):1384-7. Resumen